S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

ImExHS Stock Price, News & Analysis (ASX:IME)

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.09 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ImExHS

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.


IME Stock News Headlines

The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Insider Stock Buying Reaches AU$1.1m On ImExHS
Radiology Services Global Market Report 2023
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
Breakeven Is Near for ImExHS Limited (ASX:IME)
INDUS Announces Fiscal 2021 Third Quarter Earnings Call
When Will ImExHS Limited (ASX:IME) Breakeven?
ImExHS Limited (IME.AX)
See More Headlines
Receive IME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
12/01/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

Net Income
$-3,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$16.53 million
Book Value
A$0.40 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.37
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. German Arango
    Co-Founder, CEO, MD & Director
  • Ms. Reena Minhas
    CFO & Company Secretary
  • Dr. Jorge Marin
    Co-Founder & Chief Medical Officer
  • Mr. Andres Vanegas
    Co-Founder & Strategic Accounts Manager
  • Mr. Alexander Sanz
    Co-Founder & CTO
  • Mr. Orlando Joven
    Chief Operating Officer
  • Mr. Juan Sebastian Bonnet
    Head of Sales
  • Mr. Benjamin Brinquis
    Head of Growth














IME Stock Analysis - Frequently Asked Questions

How were ImExHS's earnings last quarter?

ImExHS Limited (ASX:IME) posted its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. ImExHS had a negative trailing twelve-month return on equity of 22.33% and a negative net margin of 21.70%.

This page (ASX:IME) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -